4.8 Article

Boosting to Amplify Signal with Isobaric Labeling (BASIL) Strategy for Comprehensive Quantitative Phosphoproteomic Characterization of Small Populations of Cells

期刊

ANALYTICAL CHEMISTRY
卷 91, 期 9, 页码 5794-5801

出版社

AMER CHEMICAL SOC
DOI: 10.1021/acs.analchem.9b00024

关键词

-

资金

  1. NIH from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [UC4 DK104167, DP3 DK110844, UC4 DK104197]
  2. National Institute of Allergy and Infectious Diseases (NIAID) [P01 AI42288]
  3. National Cancer Institute (NCI) Clinical Proteomic Tumor Analysis Consortium (CPTAC) [U24CA210955, U01 CA214116]
  4. National Institutes of General Medical Sciences (NIGMS) [P41GM103493]
  5. DOE [DE-AC05-76RL0 1830]

向作者/读者索取更多资源

Comprehensive phosphoproteomic analysis of small populations of cells remains a daunting task due primarily to the insufficient MS signal intensity from low concentrations of enriched phosphopeptides. Isobaric labeling has a unique multiplexing feature where the total peptide signal from all channels (or samples) triggers MS/MS fragmentation for peptide identification, while the reporter ions provide quantitative information. In light of this feature, we tested the concept of using a boosting sample (e.g., a biological sample mimicking the study samples but available in a much larger quantity) in multiplexed analysis to enable sensitive and comprehensive quantitative phosphoproteomic measurements with <100 000 cells. This simple boosting to amplify signal with isobaric labeling (BASIL) strategy increased the overall number of quantifiable phosphorylation sites more than 4-fold. Good reproducibility in quantification was demonstrated with a median CV of 15.3% and Pearson correlation coefficient of 0.9S from biological replicates. A proof-of-concept experiment demonstrated the ability of BASIL to distinguish acute myeloid leukemia cells based on the phosphoproteome data. Moreover, in a pilot application, this strategy enabled quantitative analysis of over 20 000 phosphorylation sites from human pancreatic islets treated with interleukin-1 beta and interferon-gamma. Together, this signal boosting strategy provides an attractive solution for comprehensive and quantitative phosphoproteome profiling of relatively small populations of cells where traditional phosphoproteomic workflows lack sufficient sensitivity.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据